EVANSON JEFF (Chief Commercial Officer) sold 13.9% of their position (164.16K shares) of OUTLOOK THERAPEUTICS, INC. on the open market
Open‑market sale worth $203.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/19/2023ACC: 0001209191-23-004118
Officer· Chief Commercial Officer
Since Nov 2018
-164.16K
Net shares
Net seller
$203.7K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
164.16K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−27.16K
Price / share
$1.31
Trade value
$35.58K
% of position
2.3%
1/17/2023
1.18M→1.15M
Common Stock
Direct
Shares
−33.74K
Price / share
$1.25
Trade value
$42.17K
% of position
2.9%
1/18/2023
1.15M→1.12M
Common Stock
Direct
Shares
−103.25K
Price / share
$1.22
Trade value
$125.97K
% of position
9.3%
1/19/2023
1.12M→1.01M
Total
Net shares
−164.16K
Net value
-$203.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2023 | S · Sale | −27.16K | $1.31 | $35.58K | 2.3% | 1.18M | 1.15M |
| Common Stock Direct | 1/18/2023 | S · Sale | −33.74K | $1.25 | $42.17K | 2.9% | 1.15M | 1.12M |
| Common Stock Direct | 1/19/2023 | S · Sale | −103.25K | $1.22 | $125.97K | 9.3% | 1.12M | 1.01M |
| Total | −164.16K | -$203.73K | ||||||
Derivative Transactions0
No derivative transactions reported